Drdgold (DRDGF) Liabilities and Shareholders Equity (2017 - 2025)

Drdgold has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $670.6 million for Q2 2025.

• Liabilities and Shareholders Equity for Q2 2025 came in at $670.6 million, up 31.66% year-over-year; the trailing twelve-month figure through Jun 2025 was $2.1 billion (up 11.96% YoY), and the FY2025 annual result was $670.6 million, up 31.66% from the prior year.
• Liabilities and Shareholders Equity came in at $670.6 million for Q2 2025 at Drdgold, up from $509.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $670.6 million in Q2 2025 to a low of $438.4 million in Q2 2023.
• The 5-year median for Liabilities and Shareholders Equity is $456.7 million (2022), against an average of $504.8 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 41.64% in 2021 and retreated 4.02% in 2023, its largest moves.
• Drdgold's Liabilities and Shareholders Equity stood at $448.9 million in 2021, then gained by 1.74% to $456.7 million in 2022, then dropped by 4.02% to $438.4 million in 2023, then gained by 16.18% to $509.3 million in 2024, then jumped by 31.66% to $670.6 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $670.6 million (Q2 2025), $509.3 million (Q2 2024), and $438.4 million (Q2 2023), per Business Quant data.